NovoCure
NVCR
NVCR
71 hedge funds and large institutions have $172M invested in NovoCure in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 78 → 71 (-7)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
42% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 26
Holders
71
Holding in Top 10
3
Calls
$6.99M
Puts
$101K
Top Buyers
| 1 | +$27.7M | |
| 2 | +$2.64M | |
| 3 | +$1.34M | |
| 4 |
RGI
River Global Investors
London,
United Kingdom
|
+$937K |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$693K |
Top Sellers
| 1 | -$2.52M | |
| 2 | -$800K | |
| 3 | -$446K | |
| 4 |
Citigroup
New York
|
-$398K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$393K |